{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:45:15Z","timestamp":1791049515076,"version":"4.1.0"},"reference-count":123,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Mutation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1002\/humu.23611","type":"journal-article","created":{"date-parts":[[2018,8,11]],"date-time":"2018-08-11T06:59:51Z","timestamp":1533970791000},"page":"1739-1751","source":"Crossref","is-referenced-by-count":77,"title":["Exploring genetic modifiers of Gaucher disease: The next horizon"],"prefix":"10.1155","volume":"39","author":[{"given":"Brad A.","family":"Davidson","sequence":"first","affiliation":[{"name":"Section on Molecular Neurogenetics; Medical Genetics Branch; National Human Genome Research Institute; NIH; Bethesda MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzeb","family":"Hassan","sequence":"additional","affiliation":[{"name":"Section on Molecular Neurogenetics; Medical Genetics Branch; National Human Genome Research Institute; NIH; Bethesda MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Joshua","family":"Garcia","sequence":"additional","affiliation":[{"name":"Section on Molecular Neurogenetics; Medical Genetics Branch; National Human Genome Research Institute; NIH; Bethesda MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Tayebi","sequence":"additional","affiliation":[{"name":"Section on Molecular Neurogenetics; Medical Genetics Branch; National Human Genome Research Institute; NIH; Bethesda MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3019-8500","authenticated-orcid":false,"given":"Ellen","family":"Sidransky","sequence":"additional","affiliation":[{"name":"Section on Molecular Neurogenetics; Medical Genetics Branch; National Human Genome Research Institute; NIH; Bethesda MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,9,11]]},"reference":[{"key":"10.1002\/humu.23611-BIB0001|humu23611-cit-0001","doi-asserted-by":"crossref","first-page":"17394","DOI":"10.1073\/pnas.0704998104","article-title":"Molecular imaging of membrane interfaces reveals mode of beta-glucosidase activation by saposin C","volume":"104","author":"Alattia","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/humu.23611-BIB0002|humu23611-cit-0002","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/humu.22381","article-title":"Characterization of variants in the glucosylceramide synthase gene and their association with type 1 Gaucher disease severity","volume":"34","author":"Alfonso","year":"2013","journal-title":"Human Mutation"},{"key":"10.1002\/humu.23611-BIB0003|humu23611-cit-0003","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/qjmed\/hcg097","article-title":"The interleukin-6 promoter polymorphism in Gaucher disease: A new modifier gene?","volume":"96","author":"Altarescu","year":"2003","journal-title":"QJM: An International Journal of Medicine"},{"key":"10.1002\/humu.23611-BIB0004|humu23611-cit-0004","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cyto.2005.03.006","article-title":"TNF-\u03b1 levels and TNF-\u03b1 gene polymorphism in type I Gaucher disease","volume":"31","author":"Altarescu","year":"2005","journal-title":"Cytokine"},{"key":"10.1002\/humu.23611-BIB0005|humu23611-cit-0005","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1074\/jbc.272.10.6510","article-title":"Metaxin is a component of a preprotein import complex in the outer membrane of the mammalian mitochondrion","volume":"272","author":"Armstrong","year":"1997","journal-title":"Journal of Biological Chemistry"},{"key":"10.1002\/humu.23611-BIB0006|humu23611-cit-0006","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s10545-012-9478-x","article-title":"Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts","volume":"35","author":"Aureli","year":"2012","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1002\/humu.23611-BIB0007|humu23611-cit-0007","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1093\/hmg\/ddv297","article-title":"Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells","volume":"24","author":"Awad","year":"2015","journal-title":"Human Molecular Genetics"},{"issue":"9","key":"10.1002\/humu.23611-BIB0121|humu23611-cit-0121","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1182\/blood.V98.9.2597","article-title":"Discrepancies between genotype and phenotype in hematology: an important frontier","volume":"98","author":"Beutler","year":"2001","journal-title":"Blood"},{"key":"10.1002\/humu.23611-BIB0008|humu23611-cit-0008","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.lab.2004.03.013","article-title":"Mutations in the gene encoding cytosolic \u03b2-glucosidase in Gaucher disease","volume":"144","author":"Beutler","year":"2004","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"10.1002\/humu.23611-BIB0009|humu23611-cit-0009","first-page":"986","article-title":"Polymorphisms in glucosylceramide (glucocerebroside) synthase and the Gaucher disease phenotype","volume":"4","author":"Beutler","year":"2002","journal-title":"The Israel Medical Association Journal"},{"key":"10.1002\/humu.23611-BIB0010|humu23611-cit-0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymgme.2009.10.189","article-title":"In silico and functional studies of the regulation of the glucocerebrosidase gene","volume":"99","author":"Blech-Hermoni","year":"2010","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1002\/humu.23611-BIB0011|humu23611-cit-0011","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1073\/pnas.92.10.4547","article-title":"Metaxin, a gene contiguous to both thrombospondin 3 and glucocerebrosidase, is required for embryonic development in the mouse: Implications for Gaucher disease","volume":"92","author":"Bornstein","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/humu.23611-BIB0012|humu23611-cit-0012","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10545-012-9561-3","article-title":"Increased glucocerebrosidase (GBA) 2 activity in GBA1 deficient mice brains and in Gaucher leucocytes","volume":"36","author":"Burke","year":"2013","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1002\/humu.23611-BIB0013|humu23611-cit-0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/504784","article-title":"High variability of Fabry disease manifestations in an extended Italian family","volume":"2015","author":"Cammarata","year":"2015","journal-title":"BioMed Research International"},{"key":"10.1002\/humu.23611-BIB0014|humu23611-cit-0014","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cell.2014.03.008","article-title":"The noncoding RNA revolution-Trashing old rules to forge new ones","volume":"157","author":"Cech","year":"2014","journal-title":"Cell"},{"key":"10.1002\/humu.23611-BIB0015|humu23611-cit-0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/CH-189004","article-title":"Genetic modifiers of severity in sickle cell disease","volume":"68","author":"Chang","year":"2018","journal-title":"Clinical Hemorheology and Microcirculation"},{"key":"10.1002\/humu.23611-BIB0016|humu23611-cit-0016","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.cell.2015.02.038","article-title":"Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis","volume":"160","author":"Chen","year":"2015","journal-title":"Cell"},{"key":"10.1002\/humu.23611-BIB0017|humu23611-cit-0017","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00439-005-0071-3","article-title":"Population stratification confounds genetic association studies among Latinos","volume":"118","author":"Choudhry","year":"2006","journal-title":"Human Genetics"},{"key":"10.1002\/humu.23611-BIB0018|humu23611-cit-0018","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ebiom.2016.11.006","article-title":"Progranulin as a novel factor in Gaucher disease","volume":"13","author":"Choy","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1002\/humu.23611-BIB0019|humu23611-cit-0019","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1515\/bchm3.1986.367.2.879","article-title":"Immunochemical characterization of two activator proteins stimulating enzymic degradation in vitro. Absence of one of them in a human Gaucher disease variant","volume":"367","author":"Christomanou","year":"1986","journal-title":"Biological Chemistry Hoppe-Seyler"},{"issue":"1","key":"10.1002\/humu.23611-BIB0122|humu23611-cit-0122","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: from molecular understanding to clinical application","volume":"16","author":"Cutting","year":"2015","journal-title":"Nature Review Genetics"},{"key":"10.1002\/humu.23611-BIB0020|humu23611-cit-0020","doi-asserted-by":"crossref","first-page":"e1003059","DOI":"10.1371\/journal.pgen.1003059","article-title":"Lamin B1 polymorphism influences morphology of the nuclear envelope, cell cycle progression, and risk of neural tube defects in mice","volume":"8","author":"Castro","year":"2012","journal-title":"PLoS Genetics"},{"key":"10.1002\/humu.23611-BIB0021|humu23611-cit-0021","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bcmd.2010.07.009","article-title":"The cytosolic \u03b2-glucosidase GBA3 does not influence type 1 Gaucher disease manifestation","volume":"46","author":"Dekker","year":"2011","journal-title":"Blood Cells, Molecules and Diseases"},{"key":"10.1002\/humu.23611-BIB0022|humu23611-cit-0022","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nbt.3863","article-title":"Characterization of noncoding regulatory DNA in the human genome","volume":"35","author":"Elkon","year":"2017","journal-title":"Nature Biotechnology"},{"key":"10.1002\/humu.23611-BIB0023|humu23611-cit-0023","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s10545-008-0868-z","article-title":"Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: An analysis of 798 patients from the ICGG Gaucher Registry","volume":"31","author":"Fairley","year":"2008","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1002\/humu.23611-BIB0024|humu23611-cit-0024","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-6606-4-17","article-title":"Genome-wide screen for modifiers of Parkinson's disease genes in Drosophila","volume":"4","author":"Fernandes","year":"2011","journal-title":"Molecular Brain"},{"key":"10.1002\/humu.23611-BIB0025|humu23611-cit-0025","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/hmg\/ddg062","article-title":"LIMP-2\/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice","volume":"12","author":"Gamp","year":"2003","journal-title":"Human Molecular Genetics"},{"key":"10.1002\/humu.23611-BIB0026|humu23611-cit-0026","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1007\/s00415-015-7868-3","article-title":"The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease","volume":"262","author":"Gan-Or","year":"2015","journal-title":"Journal of Neurology"},{"key":"10.1002\/humu.23611-BIB0027|humu23611-cit-0027","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10048-011-0293-6","article-title":"Homozygosity for the MTX1 c.184T>A (p.S63T) alteration modifies the age of onset in GBA-associated Parkinson's disease","volume":"12","author":"Gan-Or","year":"2011","journal-title":"Neurogenetics"},{"key":"10.1002\/humu.23611-BIB0028|humu23611-cit-0028","doi-asserted-by":"crossref","DOI":"10.1111\/febs.14393","article-title":"The role of glucocerebrosidase in Parkinson disease pathogenesis","author":"Gegg","year":"2018","journal-title":"The Febs Journal"},{"key":"10.1002\/humu.23611-BIB0029|humu23611-cit-0029","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00439-008-0560-2","article-title":"Identifying modifier genes of monogenic disease: Strategies and difficulties","volume":"124","author":"G\u00e9nin","year":"2008","journal-title":"Human Genetics"},{"key":"10.1002\/humu.23611-BIB0030|humu23611-cit-0030","doi-asserted-by":"crossref","first-page":"e0126153","DOI":"10.1371\/journal.pone.0126153","article-title":"The influence of genetic variability and proinflammatory status on the development of bone disease in patients with Gaucher disease","volume":"10","author":"Gervas-Arruga","year":"2015","journal-title":"PLoS One"},{"key":"10.1002\/humu.23611-BIB0031|humu23611-cit-0031","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1136\/jmg.2004.028019","article-title":"Divergent phenotypes in Gaucher disease implicate the role of modifiers","volume":"42","author":"Goker-Alpan","year":"2005","journal-title":"Journal of Medical Genetics"},{"key":"10.1002\/humu.23611-BIB0032|humu23611-cit-0032","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2013.12.005","article-title":"Lysosomal integral membrane protein-2: A new player in lysosome-related pathology","volume":"111","author":"Gonzalez","year":"2014","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1002\/humu.23611-BIB0033|humu23611-cit-0033","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00246-009-9538-7","article-title":"Vitamin D Receptor (VDR) polymorphisms in the cardiac variant of Gaucher disease","volume":"31","author":"Greenwood","year":"2010","journal-title":"Pediatric Cardiology"},{"key":"10.1002\/humu.23611-BIB0034|humu23611-cit-0034","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s10067-010-1464-9","article-title":"Effect of vitamin D receptor (VDR) genotypes on the risk for osteoporosis in type 1 Gaucher disease","volume":"29","author":"Greenwood","year":"2010","journal-title":"Clinical Rheumatology"},{"key":"10.1002\/humu.23611-BIB0035|humu23611-cit-0035","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/mds.26001","article-title":"Genetic modifiers of Huntington's disease","volume":"29","author":"Gusella","year":"2014","journal-title":"Movement Disorders"},{"key":"10.1002\/humu.23611-BIB0036|humu23611-cit-0036","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02983018","article-title":"The relative importance of principal and modifying genes in determining some human diseases","volume":"41","author":"Haldane","year":"1941","journal-title":"Journal of Genetics"},{"key":"10.1002\/humu.23611-BIB0037|humu23611-cit-0037","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1515\/hsz-2015-0144","article-title":"High \u03b2-glucosidase (GBA) activity not attributable to GBA1 and GBA2 in live normal and enzyme-deficient fibroblasts may emphasise the role of additional GBAs","volume":"396","author":"Harzer","year":"2015","journal-title":"Biological Chemistry"},{"key":"10.1002\/humu.23611-BIB0038|humu23611-cit-0038","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ymgme.2017.07.012","article-title":"The role of epigenetics in lysosomal storage disorders: Uncharted territory","volume":"122","author":"Hassan","year":"2017","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1002\/humu.23611-BIB0039|humu23611-cit-0039","doi-asserted-by":"crossref","first-page":"30889","DOI":"10.1074\/jbc.M700832200","article-title":"Klotho-related protein is a novel cytosolic neutral beta-glycosylceramidase","volume":"282","author":"Hayashi","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1002\/humu.23611-BIB0040|humu23611-cit-0040","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1093\/hmg\/ddw206","article-title":"Identification of genetic modifiers of age-at-onset for familial Parkinson's disease","volume":"25","author":"Hill-Burns","year":"2016","journal-title":"Human Molecular Genetics"},{"key":"10.1002\/humu.23611-BIB0041|humu23611-cit-0041","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1073\/pnas.68.11.2810","article-title":"Gaucher's disease: Deficiency of \u201cacid\u201d \u03b2-glucosidase and reconstitution of enzyme activity in vitro","volume":"68","author":"Ho","year":"1971","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/humu.23611-BIB0042|humu23611-cit-0042","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.tig.2015.07.006","article-title":"Strategies for imputing and analyzing rare variants in association studies","volume":"31","author":"Hoffman","year":"2015","journal-title":"Trends in Genetics"},{"key":"10.1002\/humu.23611-BIB0043|humu23611-cit-0043","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3346\/jkms.2006.21.4.733","article-title":"Upregulation of proinflammatory cytokines in the fetal brain of the Gaucher mouse","volume":"21","author":"Hong","year":"2006","journal-title":"Journal of Korean Medical Science"},{"key":"10.1002\/humu.23611-BIB0044|humu23611-cit-0044","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0888-7543(89)90319-4","article-title":"The human glucocerebrosidase gene and pseudogene: Structure and evolution","volume":"4","author":"Horowitz","year":"1989","journal-title":"Genomics"},{"key":"10.1002\/humu.23611-BIB0045|humu23611-cit-0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1086\/377136","article-title":"Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1","volume":"73","author":"Jan de Beur","year":"2003","journal-title":"American Journal of Human Genetics"},{"key":"10.1002\/humu.23611-BIB0046|humu23611-cit-0046","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.gendis.2017.05.001","article-title":"Progranulin acts as a shared chaperone and regulates multiple lysosomal enzymes","volume":"4","author":"Jian","year":"2017","journal-title":"Genes and Diseases"},{"key":"10.1002\/humu.23611-BIB0047|humu23611-cit-0047","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ebiom.2016.10.010","article-title":"Progranulin recruits HSP70 to \u03b2-glucocerebrosidase and is therapeutic against Gaucher disease","volume":"13","author":"Jian","year":"2016a","journal-title":"EBioMedicine"},{"key":"10.1002\/humu.23611-BIB0048|humu23611-cit-0048","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ebiom.2016.08.004","article-title":"Association between progranulin and Gaucher Disease","volume":"11","author":"Jian","year":"2016b","journal-title":"EBioMedicine"},{"key":"10.1002\/humu.23611-BIB0049|humu23611-cit-0049","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1073\/pnas.1616332114","article-title":"TMEM175 deficiency impairs lysosomal and mitochondrial function and increases \u03b1-synuclein aggregation","volume":"114","author":"Jinn","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/humu.23611-BIB0050|humu23611-cit-0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bcmd.2017.04.001","article-title":"A rare form of Gaucher disease resulting from saposin C deficiency","volume":"68","author":"Kang","year":"2018","journal-title":"Blood Cells, Molecules and Diseases"},{"key":"10.1002\/humu.23611-BIB0051|humu23611-cit-0051","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.celrep.2016.07.085","article-title":"Identification of modifier genes in a mouse model of Gaucher disease","volume":"16","author":"Klein","year":"2016","journal-title":"Cell Reports"},{"key":"10.1002\/humu.23611-BIB0052|humu23611-cit-0052","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1074\/jbc.274.31.21673","article-title":"Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons","volume":"274","author":"Korkotian","year":"1999","journal-title":"Journal of Biological Chemistry"},{"key":"10.1002\/humu.23611-BIB0053|humu23611-cit-0053","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/qjmed\/hch036","article-title":"Twin pairs showing discordance of phenotype in adult Gaucher's disease","volume":"97","author":"Lachmann","year":"2004","journal-title":"QJM: An International Journal of Medicine"},{"key":"10.1002\/humu.23611-BIB0054|humu23611-cit-0054","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s10038-004-0134-7","article-title":"A novel alteration in metaxin 1, F202L, is associated with N370S in Gaucher disease","volume":"49","author":"LaMarca","year":"2004","journal-title":"Journal of Human Genetics"},{"key":"10.1002\/humu.23611-BIB0055|humu23611-cit-0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12265-017-9753-1","article-title":"Exome sequencing identifies candidate genetic modifiers of syndromic and familial thoracic aortic aneurysm severity","volume":"10","author":"Landis","year":"2017","journal-title":"Journal of Cardiovascular Translational Research"},{"issue":"4","key":"10.1002\/humu.23611-BIB0123|humu23611-cit-0123","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ng.97","article-title":"Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome","volume":"40","author":"Leitch","year":"2008","journal-title":"Nature Genetics"},{"issue":"1","key":"10.1002\/humu.23611-BIB0124|humu23611-cit-0124","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hmg\/ddq454","article-title":"Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease","volume":"20","author":"Lesage","year":"2011","journal-title":"Human Molecular Genetics"},{"key":"10.1002\/humu.23611-BIB0056|humu23611-cit-0056","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bcmd.2010.09.002","article-title":"Vitamin D Receptor (VDR) polymorphic variants in patients with cancer and Gaucher disease","volume":"46","author":"Lieblich","year":"2011","journal-title":"Blood Cells, Molecules and Diseases"},{"key":"10.1002\/humu.23611-BIB0057|humu23611-cit-0057","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/gepi.21724","article-title":"The impact of improved microarray coverage and larger sample sizes on future genome-wide association studies","volume":"4","author":"Lindquist","year":"2013","journal-title":"Genetic Epidemiology"},{"key":"10.1002\/humu.23611-BIB0058|humu23611-cit-0058","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1182\/blood-2011-10-386862","article-title":"Phenotype diversity in type 1 Gaucher disease: Discovering the genetic basis of Gaucher disease\/hematologic malignancy phenotype by individual genome analysis","volume":"119","author":"Lo","year":"2012","journal-title":"Blood"},{"key":"10.1002\/humu.23611-BIB0060|humu23611-cit-0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/geno.1996.0181","article-title":"Structure and organization of the human metaxin gene (MTX) and pseudogene","volume":"33","author":"Long","year":"1996","journal-title":"Genomics"},{"key":"10.1002\/humu.23611-BIB0061|humu23611-cit-0061","doi-asserted-by":"crossref","first-page":"21665","DOI":"10.1073\/pnas.1014376107","article-title":"Decreased glucocerebrosidase activity in Gaucher disease parallels quantitative enzyme loss due to abnormal interaction with TCP1 and c-Cbl","volume":"107","author":"Lu","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/humu.23611-BIB0062|humu23611-cit-0062","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"10.1002\/humu.23611-BIB0063|humu23611-cit-0063","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/hmg\/dds535","article-title":"ITCH regulates degradation of mutant glucocerebrosidase: Implications to Gaucher disease","volume":"22","author":"Maor","year":"2013","journal-title":"Human Molecular Genetics"},{"key":"10.1002\/humu.23611-BIB0064|humu23611-cit-0064","article-title":"Review: Population structure in genetic studies-Confounding factors and mixed models","volume":"092106","author":"Martin","year":"2017","journal-title":"bioRxiv"},{"key":"10.1002\/humu.23611-BIB0065|humu23611-cit-0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2017.05.018","article-title":"Modifier genes: Moving from pathogenesis to therapy","volume":"122","author":"McCabe","year":"2017","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1002\/humu.23611-BIB0066|humu23611-cit-0066","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrg2344","article-title":"Genome-wide association studies for complex traits: Consensus, uncertainty and challenges","volume":"9","author":"McCarthy","year":"2008","journal-title":"Nature Reviews Genetics"},{"key":"10.1002\/humu.23611-BIB0067|humu23611-cit-0067","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awu020","article-title":"Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells","volume":"137","author":"McNeill","year":"2014","journal-title":"Brain"},{"key":"10.1002\/humu.23611-BIB0068|humu23611-cit-0068","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/hmg\/ddg225","article-title":"Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis","volume":"12","author":"Merryweather-Clarke","year":"2003","journal-title":"Human Molecular Genetics"},{"key":"10.1002\/humu.23611-BIB0069|humu23611-cit-0069","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0925-4439(96)00056-7","article-title":"Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease","volume":"1317","author":"Michelakakis","year":"1996","journal-title":"Biochimica Et Biophysica Acta"},{"key":"10.1002\/humu.23611-BIB0070|humu23611-cit-0070","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/mds.24886","article-title":"Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease","volume":"27","author":"Michelakakis","year":"2012","journal-title":"Movement Disorders"},{"key":"10.1002\/humu.23611-BIB0071|humu23611-cit-0071","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1073\/pnas.1400768111","article-title":"Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease","volume":"111","author":"Mistry","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/humu.23611-BIB0072|humu23611-cit-0072","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1615\/CritRevOncog.2013006145","article-title":"Gaucher disease and malignancy: A model for cancer pathogenesis in an inborn error of metabolism","volume":"18","author":"Mistry","year":"2013","journal-title":"Critical Reviews in Oncogenesis"},{"key":"10.1002\/humu.23611-BIB0073|humu23611-cit-0073","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/wrna.110","article-title":"RNAi screening: New approaches, understandings, and organisms","volume":"3","author":"Mohr","year":"2012","journal-title":"Wiley Interdisciplinary Reviews RNA"},{"key":"10.1002\/humu.23611-BIB0074|humu23611-cit-0074","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1093\/hmg\/ddu299","article-title":"Gaucher disease due to saposin C deficiency is an inherited lysosomal disease caused by rapidly degraded mutant proteins","volume":"23","author":"Motta","year":"2014","journal-title":"Human Molecular Genetics"},{"key":"10.1002\/humu.23611-BIB0075|humu23611-cit-0075","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.yexcr.2014.11.006","article-title":"Ascribing novel functions to the sarcomeric protein, myosin binding protein H (MyBPH) in cardiac sarcomere contraction","volume":"331","author":"Mouton","year":"2015","journal-title":"Experimental Cell Research"},{"key":"10.1002\/humu.23611-BIB0076|humu23611-cit-0076","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00439-016-1649-7","article-title":"MYBPH acts as modifier of cardiac hypertrophy in hypertrophic cardiomyopathy (HCM) patients","volume":"135","author":"Mouton","year":"2016","journal-title":"Human Genetics"},{"key":"10.1002\/humu.23611-BIB0077|humu23611-cit-0077","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35056009","article-title":"Modifier genes in mice and humans","volume":"2","author":"Nadeau","year":"2001","journal-title":"Nature Reviews Genetics"},{"key":"10.1002\/humu.23611-BIB0078|humu23611-cit-0078","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa1508808","article-title":"Clonal immunoglobulin against lysolipids in the origin of myeloma","volume":"374","author":"Nair","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/humu.23611-BIB0079|humu23611-cit-0079","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/acn3.292","article-title":"Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study","volume":"3","author":"Narita","year":"2016","journal-title":"Annals of Clinical and Translational Neurology"},{"key":"10.1002\/humu.23611-BIB0080|humu23611-cit-0080","doi-asserted-by":"crossref","first-page":"12859","DOI":"10.1073\/pnas.1405362111","article-title":"Nedd9 restrains renal cystogenesis in Pkd1-\/- mice","volume":"111","author":"Nikonova","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/humu.23611-BIB0081|humu23611-cit-0081","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbamcr.2012.10.030","article-title":"Identifying protein partners of CLN8, an ER-resident protein involved in neuronal ceroid lipofuscinosis","volume":"1833","author":"Passantino","year":"2013","journal-title":"Biochimica et Biophysica Acta - Molecular Cell Research"},{"key":"10.1002\/humu.23611-BIB0082|humu23611-cit-0082","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1005622001239","article-title":"The increased sensitivity of neurons with elevated glucocerebroside to neurotoxic agents can be reversed by imiglucerase","volume":"23","author":"Pelled","year":"2000","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1002\/humu.23611-BIB0083|humu23611-cit-0083","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2004.09.004","article-title":"Enhanced calcium release in the acute neuronopathic form of Gaucher disease","volume":"18","author":"Pelled","year":"2005","journal-title":"Neurobiology Disease"},{"key":"10.1002\/humu.23611-BIB0084|humu23611-cit-0084","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of \u03b2-glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell"},{"key":"10.1002\/humu.23611-BIB0085|humu23611-cit-0085","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Human Molecular Genetics"},{"key":"10.1002\/humu.23611-BIB0086|humu23611-cit-0086","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/hmg\/ddq292","article-title":"Interaction between parkin and mutant glucocerebrosidase variants: A possible link between Parkinson disease and Gaucher disease","volume":"19","author":"Ron","year":"2010","journal-title":"Human Molecular Genetics"},{"key":"10.1002\/humu.23611-BIB0087|humu23611-cit-0087","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1615\/CritRevOncog.2013006060","article-title":"Gaucher disease: A comprehensive review","volume":"18","author":"Rosenbloom","year":"2013","journal-title":"Critical Reviews in Oncogenesis"},{"key":"10.1002\/humu.23611-BIB0088|humu23611-cit-0088","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.str.2008.02.016","article-title":"Crystal structures of human saposins C and D: Implications for lipid recognition and membrane interactions","volume":"16","author":"Rossmann","year":"2008","journal-title":"Structure (London, England)"},{"key":"10.1002\/humu.23611-BIB0089|humu23611-cit-0089","doi-asserted-by":"crossref","first-page":"15573","DOI":"10.1073\/pnas.1405700111","article-title":"LIMP-2 expression is critical for \u03b2-glucocerebrosidase activity and \u03b1-synuclein clearance","volume":"111","author":"Rothaug","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/humu.23611-BIB0090|humu23611-cit-0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/BJ20050325","article-title":"The N370S (Asn 370 \u2192Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C","volume":"390","author":"Salvioli","year":"2005","journal-title":"Biochemical Journal"},{"key":"10.1002\/humu.23611-BIB0091|humu23611-cit-0091","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1074\/jbc.M116.762831","article-title":"Identification of a feedback loop involving \u03b2-glucosidase 2 and its product sphingosine sheds light on the molecular mechanisms in Gaucher disease","volume":"292","author":"Schonauer","year":"2017","journal-title":"Journal of Biological Chemistry"},{"key":"10.1002\/humu.23611-BIB0092|humu23611-cit-0092","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuron.2012.05.024","article-title":"Network organization of the Huntingtin proteomic interactome in the mammalian brain","volume":"75","author":"Shirasaki","year":"2012","journal-title":"Neuron"},{"key":"10.1002\/humu.23611-BIB0093|humu23611-cit-0093","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: Complexity in a \u201csimple\u201d disorder","volume":"83","author":"Sidransky","year":"2004","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1002\/humu.23611-BIB0094|humu23611-cit-0094","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's Disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/humu.23611-BIB0095|humu23611-cit-0095","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1080\/15476286.2014.996085","article-title":"Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells","volume":"11","author":"Siebert","year":"2014","journal-title":"RNA Biology"},{"key":"10.1002\/humu.23611-BIB0096|humu23611-cit-0096","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/hmg\/ddt052","article-title":"TFEB regulates lysosomal proteostasis","volume":"22","author":"Song","year":"2013","journal-title":"Human Molecular Genetics"},{"key":"10.1002\/humu.23611-BIB0097|humu23611-cit-0097","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1002\/humu.23611-BIB0098|humu23611-cit-0098","doi-asserted-by":"crossref","first-page":"12702","DOI":"10.1038\/s41598-017-12973-5","article-title":"The GBAP1 pseudogene acts as a ceRNA for the glucocerebrosidase gene GBA by sponging miR-22-3p","volume":"7","author":"Straniero","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1002\/humu.23611-BIB0099|humu23611-cit-0099","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.2007.53","article-title":"The emerging landscape of breast cancer susceptibility","volume":"40","author":"Stratton","year":"2008","journal-title":"Nature Genetics"},{"key":"10.1002\/humu.23611-BIB0100|humu23611-cit-0100","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/hmg\/ddp580","article-title":"Neuronopathic Gaucher disease in the mouse: Viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits","volume":"19","author":"Sun","year":"2010a","journal-title":"Human Molecular Genetics"},{"key":"10.1002\/humu.23611-BIB0101|humu23611-cit-0101","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/hmg\/ddp531","article-title":"Specific saposin C deficiency: CNS impairment and acid \u03b2-glucosidase effects in the mouse","volume":"19","author":"Sun","year":"2010b","journal-title":"Human Molecular Genetics"},{"key":"10.1002\/humu.23611-BIB0102|humu23611-cit-0102","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2012.04.024","article-title":"The role of saposin C in Gaucher disease","volume":"106","author":"Tamargo","year":"2012","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1002\/humu.23611-BIB0103|humu23611-cit-0103","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s004390000380","article-title":"Gene rearrangement on 1q21 introducing a duplication of the glucocerebrosidase pseudogene and a metaxin fusion gene","volume":"107","author":"Tayebi","year":"2000","journal-title":"Human Genetics"},{"key":"10.1002\/humu.23611-BIB0104|humu23611-cit-0104","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/367850","article-title":"Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: Implications for complexity in Gaucher disease","volume":"72","author":"Tayebi","year":"2003","journal-title":"American Journal of Human Genetics"},{"key":"10.1002\/humu.23611-BIB0105|humu23611-cit-0105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bcmd.2014.05.005","article-title":"Heterogeneous pattern of bone disease in adult type 1 Gaucher disease: Clinical and pathological correlates","volume":"53","author":"Dussen","year":"2014","journal-title":"Blood Cells, Molecules and Diseases"},{"key":"10.1002\/humu.23611-BIB0106|humu23611-cit-0106","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/nm.2901","article-title":"EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans","volume":"18","author":"Hoecke","year":"2012","journal-title":"Nature Medicine"},{"key":"10.1002\/humu.23611-BIB0107|humu23611-cit-0107","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/humu.21566","article-title":"A mutation in SCARB2 is a modifier in Gaucher disease","volume":"32","author":"Velayati","year":"2011","journal-title":"Human Mutation"},{"key":"10.1002\/humu.23611-BIB0108|humu23611-cit-0108","doi-asserted-by":"crossref","first-page":"e1003040","DOI":"10.1371\/journal.pgen.1003040","article-title":"CNOT3 is a modifier of PRPF31 mutations in retinitis pigmentosa with incomplete penetrance","volume":"8","author":"Venturini","year":"2012","journal-title":"PLoS Genetics"},{"key":"10.1002\/humu.23611-BIB0109|humu23611-cit-0109","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35066048","article-title":"Phenotype-genotype relationships in monogenic disease: Lessons from the thalassaemias","volume":"2","author":"Weatherall","year":"2001","journal-title":"Nature Reviews Genetics"},{"key":"10.1002\/humu.23611-BIB0110|humu23611-cit-0110","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/pro.5560040415","article-title":"Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase","volume":"4","author":"Weiler","year":"2008","journal-title":"Protein Science"},{"key":"10.1002\/humu.23611-BIB0111|humu23611-cit-0111","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/brain\/aws318","article-title":"Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort","volume":"136","author":"Winder-Rhodes","year":"2013","journal-title":"Brain"},{"key":"10.1002\/humu.23611-BIB0112|humu23611-cit-0112","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1101\/gr.7.10.1020","article-title":"Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: Implications for Gaucher disease","volume":"7","author":"Winfield","year":"1997","journal-title":"Genome Research"},{"key":"10.1002\/humu.23611-BIB0113|humu23611-cit-0113","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/ng.838","article-title":"Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2","volume":"43","author":"Wright","year":"2011","journal-title":"Nature Genetics"},{"key":"10.1002\/humu.23611-BIB0114|humu23611-cit-0114","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1750-1172-8-151","article-title":"Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease","volume":"8","author":"Yildiz","year":"2013","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"10.1002\/humu.23611-BIB0115|humu23611-cit-0115","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1172\/JCI29224","article-title":"Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility","volume":"116","author":"Yildiz","year":"2006","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/humu.23611-BIB0116|humu23611-cit-0116","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.clinbiochem.2015.06.004","article-title":"The effects of chemically synthesized saposin C on glucosylceramide-\u03b2-glucosidase","volume":"48","author":"Yoneshige","year":"2015","journal-title":"Clinical Biochemistry"},{"issue":"4","key":"10.1002\/humu.23611-BIB0125|humu23611-cit-0125","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1534\/genetics.109.112516","article-title":"A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila","volume":"184","author":"Zhang","year":"2010","journal-title":"Genetics"},{"key":"10.1002\/humu.23611-BIB0117|humu23611-cit-0117","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ajh.23118","article-title":"Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation","volume":"87","author":"Zhang","year":"2012","journal-title":"American Journal of Hematology"},{"key":"10.1002\/humu.23611-BIB0118|humu23611-cit-0118","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1038\/ncomms5321","article-title":"Lysosome sorting of \u03b2-glucocerebrosidase by LIMP-2 is targeted by the mannose 6-phosphate receptor","volume":"5","author":"Zhao","year":"2014","journal-title":"Nature Communications"},{"key":"10.1002\/humu.23611-BIB0119|humu23611-cit-0119","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1073\/pnas.1514005113","article-title":"Characterization of the complex formed by \u03b2-glucocerebrosidase and the lysosomal integral membrane protein type-2","volume":"113","author":"Zunke","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["Human Mutation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhumu.23611","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/humu.23611\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T16:55:56Z","timestamp":1672332956000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/humu.23611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":123,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"URL":"https:\/\/doi.org\/10.1002\/humu.23611","archive":["Portico"],"relation":{},"ISSN":["1059-7794"],"issn-type":[{"value":"1059-7794","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,11]]}}}